---
title: "High-risk HPV Prevalence and Genotype Profile in Women Living with HIV in Sierra Leone"
id: "medrxiv-7-prevalence-and-risk-factors-for-human-papillomavirus-infection-among-women"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-7-prevalence-and-risk-factors-for-human-papillomavirus-infection-among-women"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1?rss=1"
published_at: "2026-11-13T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# High-risk HPV Prevalence and Genotype Profile in Women Living with HIV in Sierra Leone
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-7-prevalence-and-risk-factors-for-human-papillomavirus-infection-among-women
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1?rss=1)
- **Published At:** 2026-11-13T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Cross-sectional study of 191 **women living with HIV** attending Connaught Teaching Hospital in Freetown, conducted September–December 2024; participants aged 25–65 years. - Mean age in the cohort was 36.8 years; 44.5% of participants reported being single and 67% were employed. - **High-risk human papillomavirus (HPV)** DNA was detected in 60 participants (31.4%; 95% CI 25.3%–38.3%). Half of HPV-positive women carried multiple serotypes. - The most frequently detected genotype was **HPV 52**, followed by **HPV 16** and HPV 51. Only 30% of HPV-positive women had genotypes **16** or **18**, the two types targeted by the bivalent vaccine. - Endocervical swabs were collected and tested for HPV DNA; analyses were performed using R (v4.4.0). Logistic regression identified former contraceptive use as independently associated with HPV positivity (adjusted OR 4.86; 95% CI 1.65–17.37; p=0.0032). - Authors reported ethical approval from the Sierra Leone Ethics and Scientific Review Committee (SLESRC NO: 012/07/2023) and stated participants gave written informed consent. - The preprint notes that HPV screening is not integrated into HIV care in Sierra Leone and suggests the need to consider broader vaccine coverage and integrated screening, while recognizing this is an observational, single-site preprint study not yet peer reviewed.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=wJQd1DI68Frnk6TOJsaRduoMOzNFzXTnw3IPGkVjAzg-1794618239.725521-1.2.1.1-XQc0A1mEmutPa4bMQXSC0q759szXh_4s5S2X8HG1g4gq0vWYPjXHQv0myMxRlOur) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Prevalence and risk factors for human papillomavirus infection among women living with HIV in Sierra Leone: A cross-sectional study [ View ORCID Profile](http://orcid.org/0000-0002-1595-4742)Darlinda Fatmata Jiba, Guang Yang, Tian Zhang, Lili Zhao, [ View ORCID Profile](http://orcid.org/0000-0002-4194-8725)Andrew J Dykens, Gibrilla F Deen, Enanga S Namanga, Matilda N Kamara, Umu Barrie, Abu Bakarr Kallon, Daniel Sesay, Sattu Issa, Umu Sesay, Miama Amy Sam-Kpakra, Olukemi Adekanmbi, Babatunde Duduyemi, Sulaiman Lakoh doi: https://doi.org/10.64898/2026.11.11.26367873 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Darlinda Fatmata Jiba 1 College of Medicine and Allied Health Sciences, University of Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Darlinda%2B%2BFatmata%2BJiba%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jiba%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADarlinda%2B%2BFatmata%2BJiba%2B) * [ORCID record for Darlinda Fatmata Jiba](http://orcid.org/0000-0002-1595-4742 "Open in new tab") * For correspondence: darlindajiba.dj@gmail.com Guang Yang 2 Department of Clinical Laboratory, the Fifth Medical Center of PLA General Hospital, Beijing, China; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Guang%2BYang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yang%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGuang%2BYang%2B) Tian Zhang 3 Department of Clinical Laboratory, the Fifth Medical Center of PLA General Hospital, Beijing, China.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tian%2BZhang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Zhang%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATian%2BZhang%2B) Lili Zhao 3 Department of Clinical Laboratory, the Fifth Medical Center of PLA General Hospital, Beijing, China.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lili%2BZhao%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Zhao%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALili%2BZhao%2B) Andrew J Dykens 4 Department of Family and Community Medicine, University of Illinois Chicago, Chicago, Illinois, United States; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andrew%2B%2BJ%2BDykens%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Dykens%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAndrew%2B%2BJ%2BDykens%2B) * [ORCID record for Andrew J Dykens](http://orcid.org/0000-0002-4194-8725 "Open in new tab") Gibrilla F Deen 5 College of Medicine and Allied Health Sciences, University of Sierra Leone, New England, Freetown, Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Gibrilla%2B%2BF%2BDeen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Deen%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGibrilla%2B%2BF%2BDeen%2B) Enanga S Namanga 6 Ministry of Health and Sanitation, Government of Sierra Leone, New England, Freetown, Sierra Leone.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Enanga%2B%2BS%2BNamanga%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Namanga%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEnanga%2B%2BS%2BNamanga%2B) Matilda N Kamara 6 Ministry of Health and Sanitation, Government of Sierra Leone, New England, Freetown, Sierra Leone.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Matilda%2B%2BN%2BKamara%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kamara%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMatilda%2B%2BN%2BKamara%2B) Umu Barrie 7 Infectious Disease Research Network, Freetown, Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Umu%2BBarrie%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Barrie%20U&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AUmu%2BBarrie%2B) Abu Bakarr Kallon 8 Ministry of Health and Sanitation, Government of Sierra Leone, New England, Freetown, Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Abu%2B%2BBakarr%2BKallon%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kallon%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAbu%2B%2BBakarr%2BKallon%2B) Daniel Sesay 8 Ministry of Health and Sanitation, Government of Sierra Leone, New England, Freetown, Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Daniel%2BSesay%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sesay%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADaniel%2BSesay%2B) Sattu Issa 8 Ministry of Health and Sanitation, Government of Sierra Leone, New England, Freetown, Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sattu%2BIssa%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Issa%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASattu%2BIssa%2B) Umu Sesay 8 Ministry of Health and Sanitation, Government of Sierra Leone, New England, Freetown, Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Umu%2BSesay%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sesay%20U&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AUmu%2BSesay%2B) Miama Amy Sam-Kpakra 8 Ministry of Health and Sanitation, Government of Sierra Leone, New England, Freetown, Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Miama%2BAmy%2BSam-Kpakra%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sam-Kpakra%20MA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMiama%2BAmy%2BSam-Kpakra%2B) Olukemi Adekanmbi 9 Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria / Department of Medicine, University College Hospital, Ibadan, Ibadan, Nigeria * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Olukemi%2BAdekanmbi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Adekanmbi%20O&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AOlukemi%2BAdekanmbi%2B) Babatunde Duduyemi 5 College of Medicine and Allied Health Sciences, University of Sierra Leone, New England, Freetown, Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Babatunde%2BDuduyemi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Duduyemi%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABabatunde%2BDuduyemi%2B) Sulaiman Lakoh 5 College of Medicine and Allied Health Sciences, University of Sierra Leone, New England, Freetown, Sierra Leone; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sulaiman%2BLakoh%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lakoh%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASulaiman%2BLakoh%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1344800/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1344800/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1344800/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1344800/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1344800/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Abstract BackgroundCervical cancer, a malignancy affecting the cervix, is the fourth most common cancer and cause of cancer-related mortality among women worldwide. This burden disproportionately affects low-resource regions, where approximately 90% of cases occur. HIV-positive women are at high risk of persistent Human Papillomavirus (HPV) infection and cervical cancer, but screening for this cancer is not yet integrated into HIV care in Sierra Leone. This study aimed to assess the prevalence and risk factors of high-risk HPV infection among women living with HIV (WLHIV) attending Connaught Hospital in Sierra Leone. Methods We conducted a cross-sectional study of women living with HIV aged 25-65 years attending the HIV clinic at Connaught Teaching Hospital in Freetown between September and December 2024. Endocervical swabs were collected for HPV DNA testing. Data was analyzed using R (v4.4.0). Logistic regression analysis was used to determine the independent risk factors for HPV positivity. Results A total of 191 WLHIV were enrolled. The mean age was 36.8 years; 44.5% were single, and 67% were employed. High-risk HPV DNA was detected in 60 (31.4%) (95% CI 25.3%-38.3%) participants, with 50% (30/60) having multiple serotypes. The most common genotype was HPV 52, followed by 16 and 51. Only 30% of HPV-positive women had genotypes 16 or 18, targeted by the bivalent vaccine. On multivariable analysis, former contraceptive use was independently associated with increased HPV positivity (aOR=4.86, 95% CI: 1.65-17.37, p = 0.0032). Conclusion The high prevalence of high-risk HPV infection and predominance of non 16/18 genotypes among WLHIV in Sierra Leone underscore the need to integrate HPV screening within HIV services and consider broader HPV vaccine coverage in Sierra Leone. Former contraceptive use is an independent predictor of HPV positivity, emphasizing the need for robust screening strategies in women using contraceptives. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial NA ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study received ethical approval from the Sierra Leone Ethics and Scientific Review Committee of the Ministry of Health, Government of Sierra Leone (referenced SLESRC NO: 012/07/2023) in accordance with the relevant guidelines and regulations and the Declaration of Helsinki. All study participants provided written informed consent before enrollment and participation. Data were anonymized and entered into a password-protected computer accessible only to the study team. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Data will be made available upon request to the corresponding author. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.11.26367872v1 "Artificial intelligence for pulmonary tuberculosis detection on chest X-ray images: A systematic review and diagnostic accuracy meta-analysis")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.11.26367883v1 "Gene-based map of cardiovascular diseases") Posted November 13, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/13/2026.11.11.26367873.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.11.26367873v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/13/2026.11.11.26367873.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Prevalence and risk factors for human papillomavirus infection among women living with HIV in Sierra Leone: A cross-sectional study Darlinda Fatmata Jiba, Guang Yang, Tian Zhang, Lili Zhao, Andrew J Dykens, Gibrilla F Deen, Enanga S Namanga, Matilda N Kamara, Umu Barrie, Abu Bakarr Kallon, Daniel Sesay, Sattu Issa, Umu Sesay, Miama Amy Sam-Kpakra, Olukemi Adekanmbi, Babatunde Duduyemi, Sulaiman Lakoh medRxiv 2026.11.11.26367873; doi: https://doi.org/10.64898/2026.11.11.26367873 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.11.26367873v1%26text%3DPrevalence%2520and%2520risk%2520factors%2520for%2520human%2520papillomavirus%2520infection%2520among%2520women%2520living%2520with%2520HIV%2520in%2520Sierra%2520Leone%253A%2520A%2520cross-sectional%2520study "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.11.26367873v1%26t%3DPrevalence%2520and%2520risk%2520factors%2520for%2520human%2520papillomavirus%2520infection%2520among%2520women%2520living%2520with%2520HIV%2520in%2520Sierra%2520Leone%253A%2520A%2520cross-sectional%2520study "Share on Facebook") [![LinkedIn logo](https://www
## Related Clinical Research

- [Impact of loss to follow-up on 5-year mortality after tuberculosis treatment in São Paulo, Brazil](https://medichelpline.com/clinical-feed/plos-medicine-0-loss-to-follow-up-during-tuberculosis-treatment-and-5-year-mortality-in-brazil.md)
- [Bayesian latent class analysis of pediatric tuberculosis diagnostics in Kenya](https://medichelpline.com/clinical-feed/medrxiv-10-using-bayesian-latent-class-models-to-evaluate-tuberculosis-diagnostics-in-a.md)
- [AI-guided nanoparticle therapeutics for infectious diseases integrating CRISPR, phage hybrids, and](https://medichelpline.com/clinical-feed/pubmed-43037917.md) (DOI: 10.1186/s11671-026-05108-1)
- [Viral suppression after test-and-treat in Ethiopia: rates and predictors in Shashemene cohort](https://medichelpline.com/clinical-feed/plos-one-21-viral-suppression-among-adolescents-and-adults-living-with-human.md)
- [Helicobacter pylori Serology and Resistant Hypertension: South African Cohort Protocol](https://medichelpline.com/clinical-feed/plos-one-20-protocol-for-investigating-the-association-between-helicobacter-pylori-exposure.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.